Fireside Chat on the Future of the FDA: Regulatory Initiatives, and Agency Developments for Hatch Waxman Practitioners to Watch

Staying abreast of the latest FDA developments enables Hatch Waxman practitioners to navigate the regulatory process efficiently and put a strategic plan in place for future litigation. This session will examine new FDA initiatives and notable developments with implications for both brand and generics.